1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Galvanize Therapeutics, Inc.

Have updates for this profile?  Please contribute data

About Deals
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2015

Location

San Carlos CA US

Primary Industry

Medical Devices & Equipment

About

Founded in 2015 by founder Jonathan Waldstreicher and based in California, US, Galvanize Therapeutics, Inc. develops energy-based medical devices to address a range of medical conditions, such as oncology, chronic bronchitis, and drug delivery. In January 2024, CardioFocus, Inc. acquired Galvanize Therapeutics, Inc. Galvanize Therapeutics' primary product is the Aliya pulsed electric field system to enhance treatment efficacy in oncology and other therapeutic areas. The Aliya system is designed to provide a non-invasive approach for tissue ablation and modulation, improving patient outcomes in conditions such as non-small cell lung cancer (NSCLC) and chronic bronchitis. The company's product portfolio includes the INUMI Flex Endoscopic Needle, which is used in conjunction with the Aliya system for soft tissue ablation.
Current Investors
Apple Tree Partners, Fidelity Investments, Intuitive Surgical

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Biotechnology, Oncology/Cancer Treatment, Therapeutic Devices
Website
www.galvanizetx.com
Verticals
Manufacturing
Company Stage
Series B/Round 2
Total Amount Raised
Subscriber access only

Deals

Deals Type
Merger
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Gala Therapeutics Inc., Galaxy Medical, Inc. 15 Sep 2022
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo